Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Certain cancer drugs can cause skin issues like rashes and itching.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Finasteride may help treat childhood brain tumors by activating certain genes.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

STAR particles are safe, comfortable, and effective for enhancing drug delivery through the skin.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Cetuximab can cause excessive eyelash growth.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Upadacitinib improved multiple immune-related conditions in one patient.